Paul Gargan

Prior to Prominex, Dr. Gargan operated his own advisory business, The Causeway Advisory Group, providing strategic direction, M&A services, transaction negotiation, fundraising, technology evaluation, due diligence, and target identification for diagnostic, medical device, and biotech companies. Dr. Gargan previously held a variety of executive leadership positions in business development and strategic planning for 15 years at Gen-Probe (now Hologic) where he spearheaded the formation, acquisition, integration, and management of numerous new businesses, strategic alliances, and corporate collaborations. During his tenure at Gen-Probe, he negotiated over 120 transactions that led to more than $2 billion in product sales. Dr. Gargan also led Gen-Probe’s M&A team for 3 years acquiring a number of strategic companies. He received his bachelor of science in Chemistry and Ph.D. in Biochemistry from Queen’s University of Belfast and master of business administration from the University of Notre Dame.